Neoadjuvant RC48 Plus Gemcitabine in HER2-Expressing MIBC

NCT07693959 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

170

Enrollment

OTHER

Sponsor class

Conditions

MIBC

Interventions

DRUG: Gemcitabine
DRUG: Toripalimab
DRUG: Disitamab Vedotin (RC48)
PROCEDURE: Radical Cystectomy

Sponsor

Zhiquan Hu

Collaborators

[object Object]